Generated at Fri, 13 Dec 2019 21:26:58 GMT exp-ck: undefined; xpa: ;
Electrode, Comp-701261235, DC-prod-cdc02, ENV-prod-a, PROF-PROD, VER-19.1.31, SHA-771c9ce79737366b1d5f53d21cad4086bf722e21, CID-14754b7c-8a0-16f012854e5e04, Generated: Fri, 13 Dec 2019 21:26:58 GMT

Algae-Based Biopharmaceuticals - eBook

$143.09$143.09
Digital delivery to your
or Kobo eReader
<p>This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.</p> <p>This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals.&nbsp;Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems.&nbsp;</p> <p>First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.</p>

About This Item

We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here, and we have not verified it.

This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. 

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

Algae-Based Biopharmaceuticals - eBook

Specifications

Read This On
Android,Ereader,Desktop,IOS,Windows
Is Downloadable Content Available
Y
Digital Reader Format
Epub (Yes)
Language
en
Publisher
Kobo
Author
Sergio Rosales-Mendoza
ISBN-13
9783319322322
ISBN-10
331932232X

Customer Reviews

Be the first to review this item!

Customer Q&A

Get specific details about this product from customers who own it.

Policies & Plans

Pricing policy

About our prices
We're committed to providing low prices every day, on everything. So if you find a current lower price from an online retailer on an identical, in-stock product, tell us and we'll match it. See more details atOnline Price Match.
webapp branch
Electrode, Comp-389264332, DC-prod-cdc01, ENV-prod-a, PROF-PROD, VER-30.0.3-ebf-2, SHA-8c8e8dc1c07e462c80c1b82096c2da2858100078, CID-ed34213c-ab2-16f012db0a3835, Generated: Fri, 13 Dec 2019 21:32:49 GMT